Advisory Board and Editors HIV

Journal Factsheet
A one-page PDF to help when considering journal options with co-authors
Download Factsheet
I told my colleagues that PeerJ is a journal where they need to publish if they want their paper to be published quickly and with the strict peer review expected from a good journal.
Sohath Vanegas,
PeerJ Author
View author feedback

Christian L Althaus

Head of Research Group at the Institute of Social and Preventive Medicine at the University of Bern (Switzerland). Christian Althaus uses mathematical and computational modeling in combination with data analyses to investigate how the population biology of infectious diseases is affected by environmental changes, dynamic patterns of host immunity, or public health interventions. Key areas of his research are the transmission and control of sexually transmitted infections (STI), antimicrobial resistance and emerging infectious diseases.

Zandrea Ambrose

Associate Professor in the Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine.

Hidayat Arifin

Hidayat Arifin is a faculty member of the Faculty of Nursing, Universitas Padjadjaran, Indonesia. He works as a researcher, academic editor, and reviewer in national and international journals. His research interests and area of expertise include medical-surgical nursing, adult nursing, non-communicable diseases, and secondary data analysis in healthcare.

Stefan D Baral

Stefan Baral is a physician epidemiologist and an Associate Professor in the Department of Epidemiology at the Johns Hopkins School of Public Health (JHSPH). Stefan has led epidemiological studies among key populations including men who have sex with men and sex workers in Southern, Eastern, and Western African countries as well as in Central and Southeastern Asia. Stefan acts as the Director of the Key Populations Program for the Center for Public Health and Human Rights at the JHSPH.

Joshua S Davis

Josh is a clinician researcher, and divides his time between clinical work as an Infectious Diseases physician in Newcastle, and research work as a principal research fellow based at Menzies.

He completed his clinical infectious diseases training in 2004, and then worked on a PhD from 2007-2010 on the epidemiology, pathophysiology and adjunctive treatment of sepsis in the Top End of the Northern Territory (NT).

His main clinical interests are general infectious diseases, viral hepatitis, refugee health and infections in the critical care setting. His main research interests are clinical trials in the management of severe infections and epidemiology of severe bacterial infections.

Josh is the past president of the Australasian Society for Infectious Diseases (ASID) and is a career development fellow of Australia's National Health and Medical Research Council. In the 10 years since completing his PhD, he has over 140 peer-reviewed publications and an h-index of 31.

Carlos de Noronha

Dr. Carlos de Noronha is Associate Professor within the Department of Immunology and Microbial Disease at Albany Medical College, USA.

His research focus is in the field of Microbiology, more specifically HIV, Molecular Virology, Viral Infection, Virus Diseases, Viral Immunology, Immunology of Infectious Diseases and Emerging Infectious Diseases.

Barbara Ensoli

Director of the National AIDS Center, Istituto Superiore di Sanità, Rome, Italy. Co-Vice President and Member of the Presidential Committee of the AIDS National Commission, Ministry of Health. Member of the European Molecular Biology Organisation (EMBO).

Simon DW Frost

Reader in Pathogen Dynamics at the University of Cambridge; formerly Adjunct Associate Professor in the Dept. of Pathology, University of California San Diego (UCSD). Graduated with a BA in Natural Sciences (1st class), Trinity College, Cambridge (1992), DPhil in Mathematical Biology, Merton College, Oxford (1996). Postdoctoral positions at Princeton University, Oxford University, University of Edinburgh and UCSD. Awards include: NATO Postdoctoral Fellowship (1996), MRC Nonclinical Training Fellowship (1997-2000), a Royal Society Wolfson Research Merit Award (2008-2013), and Thomson-Reuters Highly Cited Researcher awards in 2014, 2015, and 2016.

Shou-Jiang (SJ) Gao

Dr. Gao is a Professor and Director of the Cancer Virology Program at the Hillman Cancer Center and in the Department of Microbiology and Molecular Genetics in the University of Pittsburgh School of Medicine.

Dr. Gao is an Elected Fellow of the American Academy of Microbiology. He currently serves as the Editor-In-Chief for the Journal of Medical Virology, Section Editor for PLoS Pathogens, and Academic Editor for PLoS One and PeerJ. He is also serving on the Editorial Boards of over 10 peer-reviewed journals including Journal of Virology, Journal of Antivirals & Antiretrovirals, Journal of Molecular Biomarkers and Diagnosis, Journal of Microbial & Biochemical Technology, Sarcoma Research International, Oncolytic Virotherapy, etc.

Delia Goletti

Delia Goletti MD, PhD, Infectious Diseases specialist. In 1992 she joined the Laboratory of Immunoregulation at the National Institutes of Health (chief Dr Fauci) working on HIV pathogenesis. In 1999 she joined the National Institute for Infectious Diseases in Rome. She has clinical duties on the tuberculosis (TB) clinic and responsibility of the Translational Research Unit where she works on TB pathogenesis, TB immunodiagnostic tests and impact of Heminths infection on HIV and TB disease.

Grant A Hill-Cawthorne

Senior Lecturer in Communicable Disease Epidemiology, School of Public Health, University of Sydney; Public Health Lead and Node Leader for Mass Gathering Medicine, Marie Bashir Institute, University of Sydney; Honorary Life Fellow, St Andrew's College within the University of Sydney; Senior Member and College Research Associate, Wolfson College, University of Cambridge

Biographical details:
I studied medicine in Cambridge and during my junior doctor years was very interested in both neurology and infectious diseases. Clinically I specialised in medical microbiology, keeping a particular interest in neurological infections. For the past 3 years I have been in Saudi Arabia developing a pathogen genomics laboratory where I have gained first-hand experience of second generation sequencing and bioinformatics.

Research interests:
Infectious diseases and medical microbiology are undergoing the most significant shift since PCR was introduced. By the end of this decade, sequencing will have become the main option when investigating any outbreak or infection. I study the interface between genomics as a pure science and its translation into clinical and public health benefits.

At present I am examining the worldwide genomics of tuberculosis, the use of sequencing to characterise MRSA strains and the genomic variations in BCG vaccine strains used around the globe.

Bill Hooker

PhD = cloning and characterizing potential vaccine antigens from schistosomes; first postdoc = fine details of HIV replication (with David Harrich); second postdoc = best ignored; third postdoc = role of Max network, especially Mnt, in cancer and development (with Peter Hurlin). After that I made HIV POC tests and other diagnostic devices in two small biotech companies. Now I'm a research manager with Canon US Life Sci.